Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
Lymphoid progenitors as candidate cancer stem cells in AML: New perspectives.
Cell Cycle 6, 543-545 (2007)
Mouse models have demonstrated that both hematopoietic stem cells (HSCs) as well as downstream myeloid progenitors can be targets of transformation in AML. We recently showed in a murine model of the CALM/AF10 fusion gene positive leukemia, that progenitors with lymphoid characteristics can be leukemic stem cell (LSC) candidates in AML. We could demonstrate that the LSC candidate in the CALM/AF10 murine model was positive for the lymphoid associated surface antigen B220, which was not expressed by the leukemic bulk or the normal HSC pool. This offers the intriguing possibility to target the LSCs with antibodies that spare the normal stem cell.
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
CALM/AF10; leukemic stem cells; AML; targeted therapy
ISSN (print) / ISBN
1538-4101
e-ISSN
1551-4005
Journal
Cell Cycle
Quellenangaben
Volume: 6,
Issue: 5,
Pages: 543-545
Publisher
Landes Bioscience
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
CCG Pathogenesis of Acute Myeloid Leukemia (KKG-KPL)